Evaluation of large scale clinical trials and their application to usual practice.
作者信息
Tonkin A M
机构信息
National Heart Foundation of Australia, Austin and Repatriation Medical Centre, Melbourne, Australia.
出版信息
Heart. 2000 Dec;84(6):679-84. doi: 10.1136/heart.84.6.679.
Abstract
摘要
相似文献
1
Evaluation of large scale clinical trials and their application to usual practice.大规模临床试验的评估及其在常规实践中的应用。
Heart. 2000 Dec;84(6):679-84. doi: 10.1136/heart.84.6.679.
2
What is right and what is wrong about evidence-based medicine?循证医学的是与非？
J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S2-5. doi: 10.1046/j.1540-8167.14.s9.18.x.
3
Issues in subgroup analyses and meta-analyses of clinical trials.临床试验亚组分析和荟萃分析中的问题
J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S6-8. doi: 10.1046/j.1540-8167.14.s9.1.x.
4
Principles from clinical trials relevant to clinical practice: Part II.与临床实践相关的临床试验原则：第二部分。
Circulation. 2002 Aug 27;106(9):1172-5. doi: 10.1161/01.cir.0000023218.39412.32.
5
[Recommendations for prevention and evidence-based medicine].[预防建议与循证医学]
Z Kardiol. 2005;94 Suppl 3:III/1-5. doi: 10.1007/s00392-005-1301-3.
6
The Future of Clinical Trials in Cardiovascular Medicine.心血管医学临床试验的未来。
Circulation. 2016 Jun 21;133(25):2662-70. doi: 10.1161/CIRCULATIONAHA.115.020723.
7
The need for multicentre cardiovascular clinical trials in Asia.亚洲需要开展多中心心血管临床试验。
Nat Rev Cardiol. 2013 Jun;10(6):355-62. doi: 10.1038/nrcardio.2013.49. Epub 2013 Apr 16.
8
The role of nonrandomized trials in the evaluation of oncology drugs.非随机临床试验在肿瘤药物评价中的作用。
Clin Pharmacol Ther. 2015 May;97(5):502-7. doi: 10.1002/cpt.86. Epub 2015 Apr 7.
9
Critical appraisal of trials for validation of 'risk-guided' cardiovascular disease prevention therapy.临床试验的批判性评价，用于验证“风险导向”的心血管疾病预防治疗。
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):33-6. doi: 10.1177/2047487312448986.
10
Smaller trials for better evidence.
Br J Psychiatry. 2004 Mar;184:270. doi: 10.1192/bjp.184.3.270.
引用本文的文献
1
Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.心血管临床试验中老年人和女性的代表性不足吗？对治疗的影响。
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):433-438. doi: 10.1007/s00508-016-1082-x. Epub 2016 Sep 21.
本文引用的文献
1
Non-invasive coronary artery imaging with electron beam computed tomography and magnetic resonance imaging.采用电子束计算机断层扫描和磁共振成像进行无创冠状动脉成像。
Heart. 2000 Oct;84(4):442-8. doi: 10.1136/heart.84.4.442.
2
Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey.不同专业群体和普通人群服用抗高血压药物的阈值：问卷调查
BMJ. 2000 May 27;320(7247):1446-7. doi: 10.1136/bmj.320.7247.1446.
3
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.氯沙坦与卡托普利对有症状心力衰竭患者死亡率影响的比较：随机试验——氯沙坦心力衰竭生存研究（ELITE II）
Lancet. 2000 May 6;355(9215):1582-7. doi: 10.1016/s0140-6736(00)02213-3.
4
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.
Circulation. 2000 May 16;101(19):2239-46. doi: 10.1161/01.cir.101.19.2239.
5
A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society.法国医院心力衰竭情况的全国性调查。法国心脏病学会心肌病与心力衰竭工作组、国立综合医院心脏病专家学院以及法国老年病学会。
Eur Heart J. 2000 May;21(9):763-9. doi: 10.1053/euhj.1999.1762.
6
Cost effectiveness of the implantable cardioverter defibrillator.
Eur Heart J. 2000 May;21(9):712-9. doi: 10.1053/euhj.1999.1878.
7
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect.医学文献用户指南：第十九篇。应用临床试验结果 B. 判断一种药物是否产生（超过）类效应的指南。
JAMA. 1999 Oct 13;282(14):1371-7. doi: 10.1001/jama.282.14.1371.
8
Cause of death in clinical research: time for a reassessment?临床研究中的死因：是时候重新评估了吗？
J Am Coll Cardiol. 1999 Sep;34(3):618-20. doi: 10.1016/s0735-1097(99)00250-8.
9
Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading.荟萃分析得出的需治疗人数——有时提供信息，通常具有误导性。
BMJ. 1999 Jun 5;318(7197):1548-51. doi: 10.1136/bmj.318.7197.1548.
10
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.临床实践中冠心病的预防：欧洲及其他学会冠心病预防联合特别工作组第二次报告建议
Atherosclerosis. 1998 Oct;140(2):199-270. doi: 10.1016/s0021-9150(98)90209-x.
Zotero 插件